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Abstract
The COVID-19 pandemic is an unprecedented global emergency. Clinicians and medical 
researchers are suddenly thrown into a situation where they need to keep up with the lat-
est and best evidence for decision-making at work in order to save lives and develop solu-
tions for COVID-19 treatments and preventions. However, a challenge is the overwhelming 
numbers of online publications with a wide range of quality. We explain a science gateway 
platform designed to help users to filter the overwhelming amount of literature efficiently 
(with speed) and effectively (with quality), to find answers to their scientific questions. It 
is equipped with a chatbot to assist users to overcome infodemic, low usability, and high 
learning curve. We argue that human-machine communication via a chatbot play a critical 
role in enabling the diffusion of innovations. 
Keywords: COVID-19, science gateways, chatbot, human-machine communication, 
diffusion of innovations
Introduction
The COVID-19 pandemic is one of the world’s greatest crises in the new millennium. As of 
May 2021, about 163 million people worldwide contracted the SARS-CoV-2 coronavirus, 
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it is estimated that the pandemic led to a USD 3.94 trillion loss in economic output glob-
ally during 2020, approximately a 4.5% drop in gross domestic product (GDP) (Szmigi-
era, 2021). The unprecedented impacts will have lasting effects for many years. During the 
pandemic, many new ideas have been implemented to address the various problems that 
stemmed from the pandemic, including in the areas of infection prevention and control, 
public health measures, and so forth. As the old saying goes, “Necessity is the mother of 
invention.” New technologies, practices, behaviors, approaches, and so forth, are often 
developed as solutions to difficult problems people face. 
Chatbot can be used for many creative solutions for problems during the pandemic 
(Mehfooz et al., 2021). For example, one of the major problems during the pandemic lies 
in the testing or screening of patients for COVID. However, the volumes are overwhelm-
ing, and health care workers are at risk of being exposed to the virus during the testing/ 
screening process. This is where machines (e.g., chatbots) can help. In addition to work-
ing with patients with non-direct contacts and reducing the risks on health care workers, 
machines can work tirelessly to address the rapid surge in cases, and can also adapt to 
multiple languages (Martin et al., 2020). Human-machine communication (HMC) between 
a multilingual chatbot and patients around the world can improve both the effectiveness 
(with the latest COVID-19 information) and efficiency (with around-the-clock communi-
cation with patients) of addressing the pandemic. We define HMC as the communication 
between humans and machines in accomplishing the common goals of identifying the best 
care possible for patients and the best research evidence for treatment and prevention strat-
egies. Therefore, HMC plays a crucial role in the global efforts in combating COVID-19 
during the pandemic.
Researchers have experimented with chatbots to answer questions about COVID-19 
(VolppKevin, 2020). In Thailand, a chatbot was designed to answer questions about topics 
such as how to protect oneself from coronavirus, self-screening for symptoms, a list of near-
est hospitals, fake news about COVID-19, and so forth (Rodsawang et al., 2020). During 
the pandemic, patients cannot easily see their primary care doctors in person for regular 
non-COVID cases. In India, Medbot was created to be a chatbot that can provide telemed-
icine in place of a doctor, providing advice and tips on general preventive measures, check-
ing symptoms, suggesting home remedies, and providing counseling for general well-being 
(Bharti et al., 2020). Chatbots have also been used to perform tele-psychiatry for patients 
suffering from pathological social withdrawal, intensified by the stay-at-home orders, lock-
downs, and social distancing (Yoshikawa et al., 2021). Beyond health care applications (Ling 
& Björling, 2020), chatbots have also been incorporated into crisis reporting and news plat-
forms, to help deliver timely information about COVID-19 to the public (Maniou & Veglis, 
2020). 
Innovations are needed for filtering the surplus scientific literature on COVID-19 so 
that clinicians and medical researchers can efficiently seek and learn from the most recent 
and relevant publications (Oruche et al., 2021). This article seeks to explore the research 
question: “How can an AI-powered chatbot help users, especially clinicians and medical 
researchers, effectively and efficiently identify reliable information with high evidence levels to 
help them make the best decisions at work?” Answers to this question can shed light on how 
HMC contributes to the diffusion of innovations (Rogers, 2003) for combating the COVID-
19 pandemic in the present moment. Furthermore, answers to this question can help us 
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understand how HMC contributes to the new normal in the post-pandemic world as well as 
how HMC can better prepare us for the next pandemic or global emergency, where similar 
challenges such as those related to the current pandemic re-emerge in the future.
HMC research on machine’s advice-giving suggests that the difficulty of the tasks 
and perceived machine’s understanding of decision consequences matter in human users’ 
advice utilization (Prahl & Van Swol, 2021). Given the low usability and high technicality of 
many gateways as well as the scientific and societal significance of having the latest and best 
COVID-19 literature for clinicians and medical researchers in combating the pandemic, a 
study on an advice-giving chatbot can help advance HMC research in designing machines 
that will enjoy a higher degree of acceptance, adoption, and utilization by users. Although 
some HMC scholars are concerned about negative effects of machines replacing humans at 
the workplace (Gibbs et al., 2021; Piercy & Gist-Mackey, 2021) and raised ethical questions 
in critical studies on HMC (Dehnert & Leach, 2021; Liu, 2021), the potential positive conse-
quences of a machine-driven solution can help clinicians and medical researchers save lives, 
a task that Prahl and Van Swol (2021) would term humanitarian. Hence, a machine-driven 
solution may be well-received in HMC research.
In this article, we explain a science gateway platform called KnowCOVID-19 (Oruche 
et al., 2021), equipped with a chatbot called Vidura (Chandrashekara et al., 2018). Know-
COVID-19 is designed to automatically sort scientific literature based on different types 
of evidence (e.g., empirical studies versus expert opinions). Named after a wise advisor 
in Indian mythology, Vidura is a chatbot designed to guide users to navigate the platform 
to effectively (with quality) and efficiently (with speed) find the scientific literature with 
the desired type of evidence to help clinicians and medical researchers combat the pan-
demic, including giving the best care to patients with COVID-19 as well as discovering 
treatments and preventions for the disease. Both the gateway and the chatbot are in the 
prototype phase under a collaborative project funded by the National Science Foundation 
in the United States (see Calyam & Nair, 2020; Kee, 2020).
Given the urgent need to develop a chatbot to leverage HMC to combat the COVID-19 
pandemic, this article will first define the machine (i.e., a science gateway integrated with 
an AI-powered chatbot) central to the core of this article. Second, we elaborate on the main 
problems faced by users in our specific context of scientific literature searches on COVID-
19. Third, we explain how three novel solutions can be integrated into technologies to help 
overcome the stated problems. Fourth, we briefly describe the functions of a gateway plat-
form and a chatbot to help users with optimizing scientific literature searches on COVID-
19. Fifth, we propose how the adoption of our chatbot can be further studied, using a mix 
of methods commonly used in communication and HMC research. Finally, this article con-
cludes by providing some theoretical and practical implications of the role of chatbot and 
HMC in diffusion research.
AI-Powered Chatbot Integrated With a Science Gateway for 
COVID-19
It is important to discuss the concepts of artificial intelligence (AI) and chatbot. AI involves 
“the study of agents that exist in an environment and perceive and act” (Russell & Norvig, 
1995, p. 5). AI is not simply a computer program, but a smart computer program (often 
50 Human-Machine Communication 
referred to as a computer agent) that can simulate human thoughts and actions toward 
optimal outcomes according to specified goals. AI-driven machines are often said to mimic 
the human minds in order to learn and solve problems at a higher scale and with a higher 
reliability that is not feasible manually. 
AI involves machine learning (ML) and deep learning (DL). ML is a technique that 
allows computers to improve its performance based on inputs and experiences. On the other 
hand, DL is a technique to program computers to learn, modeling after human multilayer 
neuro networks. Given these techniques, AI-powered machines can augment human func-
tions at large scales through automation and further improve their performance through 
recommendation of a set of viable options for humans to consider to process data. In this 
article, AI in the form of topic models of data and recommender engines to provision com-
putational resources provides much of the foundation of how our Vidura chatbot operates 
in improving the effectiveness and efficiency of KnowCOVID-19 science gateway to filter 
huge publication archives of information.
Chatbot, one of the most prevalent practical AI examples, is a conversational agent 
that imitates human-to-human conversations. There are text-based chatbots (e.g., Bank of 
America’s Erica, Capital One’s Eno, Geico’s Kate, Amtrak’s Julie, etc.) (Ali, 2021) and voice-
based chatbots (e.g., Amazon Alexa, Apple Siri, Google Assistant, Microsoft Cortana, etc.) 
(Etzrodt & Engesser, 2021). As alluded to in the previous paragraph, although users directly 
interact with the chatbot such as Erica and Alexa, the AI algorithms form an integral part 
of the users’ experience with the chatbot. Therefore, the concepts of AI and chatbot can be 
treated as one, as the chatbot cannot function properly without AI, and the AI is not usable 
without a well-designed chatbot user interface. 
More recently, the bibliometric study on chatbots (Io & Lee, 2017) reveals the scope of 
contributions in the state-of-the-art for chatbot applications in many domains with a high 
number of alternatives and thus justifies the need for (semi-)automated user support. This 
also confirms the novelty of our contribution to science gateway communities, since, to the 
best of our knowledge, there is no prior work in this area. In other recent works, a new cate-
gory of conversational agents with chatbot interfaces enables natural language processing to 
map suitable commands for their execution to provide convenience for user requirement. 
An example is implemented in prior work (Bieliauskas & Schreiber, 2017) for a conversa-
tional visualization service to extract keywords from the conversation and to apply filters to 
the visualizations. Such methods are helpful in data science applications as they allow nov-
ice users to build data models with minimal coding. Chatbots for data analysis workflow 
management such as AVA (John et al., 2017) and more recently IRIS (Fast et al., 2018) are 
promising solutions that further motivate our work, and the benefits that we expect for the 
science gateway communities. 
A science gateway refers to a “community-specific set of tools, applications, and data 
collections that are integrated together via a portal or a suite of applications, providing 
access to grid-integrated resources” (Wilkins‐Diehr, 2006, p. 743). Via a web-based graphi-
cal user-interface, data providers share their data with a community of users and other pro-
viders. On the other hand, users can access shared resources, such as software, instruments, 
(de-identified) data, computing (cloud) services, educational materials as well as discipline- 
specific knowledge as a diverse community of users (SGCI, 2020). In other words, a gateway 
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is a point-and-click platform to help users harness and process big data through web ser-
vices of computational resources.
What is the big data in this article? As previously mentioned, the amount of scientific 
literature in publication archives such as PubMed (NCBI, 2020), LitCovid (NLM, 2020) 
being produced on COVID-19 is vast and fast-growing, which has reached an overwhelm-
ing state for clinicians and medical researchers. Not only is the data big in size, today’s 
big datasets are often characterized by multiple parameters (Mayer-Schönberger & Cukier, 
2014). As a result, many clinicians and medical researchers are unable to keep up with the 
volume of information being produced daily. We further elaborate on this problem of data 
deluge along with two other related challenges in the next section. 
The Three Problems of Big Data, Quality, and Diffusion
In our particular context of scientific literature searches, clinicians and medical researchers 
face three major problems that we termed the big data problem, the quality problem, and 
the diffusion problem. First, the big data problem. The amount of literature being produced 
on COVID-19 is vast and fast-growing, exponentially higher than any other topic in scien-
tific research prior to the pandemic. This is understandable given the urgency of the global 
emergency. Many researchers across the world are devoting their time and concerted efforts 
to combat the pandemic. However, the size of the data is so overwhelming that it created a 
dilemma for clinicians and medical researchers in that they cannot keep up with the litera-
ture. Furthermore, the data size makes it difficult for clinicians and medical researchers to 
find the exact information with the desired level of evidence they need for their individual 
work in combating COVID-19.
Second, is the quality problem. The traditional peer-review process is long and slow, as 
a paper needs to undergo multiple rounds of peer reviews and authors’ revisions before it 
can be accepted for publication. This process can sometimes take several months to a cou-
ple of years, depending on the journals. Although this process ensures a high level of quality 
for the publications, COVID-19-related research cannot wait to undergo such a lengthy 
process. Otherwise, published findings will be outdated and/or miss the opportunity win-
dows to save lives. The need to rush through the traditional peer review process is apparent, 
given the urgency to share COVID-related medical findings across the world. When the 
peer review process is rushed, the quality of review is compromised. In many situations, the 
urgency also pushed researchers to publish their results in the form of pre-prints. Pre-prints 
are research papers that can be made publicly available online immediately. Furthermore, 
some of the pre-prints are recommendations based on expert opinions, and not empiri-
cal studies. Therefore, the quality of evidence varies widely. This creates the data quality 
problem, which in turn impacts the data reliability as a clinician performs searches with 
keywords and then manually sorts through a wide range of literature with varying quality 
to make decisions that are critical for patient care.
Third, the diffusion problem. Although science gateways are designed with a web-
based user-interface with the goal of removing the need for command-line programming 
to harness big data, individual adoption and systemic diffusion is still heavily compromised 
(Kee et al., 2021). This is understandable given that gateways are built for specific purposes, 
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and many of them suffer from a low level of usability when more functionality is added 
over time. Many of the prototype gateways were developed by lead-users who cannot find 
off-the-shelf solutions to their big data problems in scientific research. Therefore, these 
prototype gateways were developed for their own use and the use of a small initial group 
of peers and collaborators who may not be concerned about usability (Kee et al., 2016). 
However, the lead users’ willingness to tolerate a low level of usability can be a big barrier 
to mass adoption beyond the initial small group or when additional functionality needs to 
be added or enhanced. A related issue is the lack of technical support, especially 24-hour 
around-the-clock and 7 days a week (Kee et al., 2021). The issue is further compounded by 
the fact that user support is time-intensive, often requiring one-on-one help and training 
(Nair & Calyam, 2018). Therefore, while gateways are a promising solution, the adoption 
and diffusion are challenged by the limitations in usability and user support. In this partic-
ular article, the diffusion problem refers to the need for users to quickly learn how to use 
the KnowCOVID-19 gateway and to receive technical support, such that the adoption and 
diffusion of this gateway innovation can be sustained over time to combat the pandemic.
These three problems of big data, quality, and diffusion present the challenges we seek 
to overcome with a gateway KnowCOVID-19. By leveraging Vidura, an AI-powered chat-
bot, to assist users to conduct literature searches, clinicians and medical researchers can 
improve the quality of the information they find. The next section explains how Know-
COVID-19 and Vidura, the gateway and chatbot, help overcome the three stated problems. 
Gateways, Levels of Evidence, and Chatbots as Solutions to the 
Three Problems
To address the big data problem, science gateways have been developed in different domains, 
such as neuroscience, physics, chemistry, and material science (Vekaria et al., 2020). Gate-
ways have also integrated smart devices to provide smart solutions for health care pro-
fessionals and patients (Chandrashekara et al., 2018). In our case, clinicians and medical 
researchers can access a wide scope of online literature on COVID-19 (text-based data ana-
lytics) to help them find the answers to their questions as the starting point. As a computer 
science technique, topic modeling of existing scientific literature can be leveraged (Zhang 
et al., 2018), thus sorting literature into topics based on clinical queries and categories based 
on specific clinical groupings. Furthermore, although it was discussed earlier that an over-
whelming volume of literature is a problem, big data also provide advantages over small 
data. For example, the gateway can include scientific literature on studies of previous coro-
navirus, such as MERS in 2012–2013 and SARS in 2002–2003. Such an approach can allow 
users to run correlational and/or associational analyses to identify longer-term patterns in 
the literature for infectious diseases and display the results and findings via visualizations. 
Second, to address the quality problem, we turn to what has become known as the 
Levels of Evidence (LOE) by Ackley et al. (2008). Briefly, LOE distinguishes the types of 
evidence used in a paper, assigning them from level VII (the lowest level) if the evidence is 
based on expert opinions to level 1 (the highest level) if the evidence is based on a system-
atic review or a meta-analysis of multiple rigorous studies, such as randomized controlled 
trials. Greenhalgh (2014) expanded on the notion and ranked the different types of evi-
dence based on a hierarchy using a pyramid, listing meta-analysis at the top of the pyramid, 
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followed by systematic review, critically appraised topic, critically appraised articles, ran-
domized controlled trials, cohort study, case-control study, background information/expert 
opinions, and finally animal research/lab studies. LOE provides an objective way to rank 
the overwhelming number of COVID-related publications and help clinicians and medical 
researchers filter through the sea of literature to identify the best quality evidence for their 
practice. Essentially, the gateway is designed to allow users to search and retrieve a large 
quantity of scientific and medical literature on health care topics related to COVID-19, and 
then sort the literature based on the pre-determined hierarchy of evidence to help users 
expedite and optimize their search process to obtain the best results.
Third, to address the diffusion problem, a chatbot assistant is designed to provide user 
support around the clock. Chatbot assistants have been implemented to provide user sup-
port in various industries, such as banking, customer service, and online education (Baby et 
al., 2017; Muslih et al., 2018; Ni et al., 2017; Zhang et al., 2018). The same idea can be applied 
to user support for using gateways. By combining the solutions of all three problems, the 
gateway can remove the burden of manual searches and a high learning curve due to a 
gateway’s low usability and technical difficulty, by leveraging the chatbot assistant powered 
by AI in the form of recommender engines, topic models of datasets, and other techniques.
The KnowCOVID-19 Gateway and the Vidura Chatbot
For the purpose of developing the KnowCOVID-19 gateway, more than 10,000 publica-
tions were gathered from the Kaggle COVID-19 Open Research Dataset (CORD-19) (Eren 
et al., 2020). Based on this dataset, users can perform three general activities with the lit-
erature searches. First, using the gateway, users can enter keywords and search terms and 
identify the levels of evidence they are interested in finding. As previously discussed, the 
total amount of literature has a wide range of quality. By identifying specific levels of evi-
dence, users can narrow their search results to particular types of evidence they believe to 
be credible and appropriate for their purpose associated with certain keywords. 
Second, users can select the articles from the search results generated by the gateway. 
They can simply use these articles for information and guidance on their practice and work. 
However, and third, the gateway allows the users to perform further analysis of the selected 
articles, using techniques such as correlational analyses to identify patterns among the arti-
cles, and they can share the results further using social network platforms. The goal of these 
features is to allow users to customize their searches and to help them extract insights from 
the searches. 
On the other hand, the Vidura chatbot is powered by Google Dialogflow, a natural 
language understanding (NLU) platform. Google Dialogflow was selected because it makes 
integration of user interface with mobile and web applications as well as interactive voice 
response systems and smart devices easy. Through analyzing users’ queries, the chatbot 
identifies the intents of the users. Then when users type their questions as input to the 
chatbot, the chatbot matches the input and intents through a technique called intent classi-
fication. Intent classification can help the chatbot extract useful information for the users. 
In order to improve the chatbot performance, it employs variation inputs from the users to 
train the NLU model. 
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To further improve the chatbot performance, the gateway will provide users with an 
online questionnaire upon signup to determine their domain proficiency (i.e., knowledge 
about COVID-19) and technology proficiency (i.e., experience with gateways in general). 
By categorizing the two proficiencies into high versus low, a two-by-two matrix can be cre-
ated. Then, each diverse user can be put in one of the four quadrants (i.e., high in domain 
proficiency but low in technology proficiency; low in both domain and technology pro-
ficiencies). Then the chatbot will provide personalized responses according to individual 
users’ position on the matrix, even if they ask the same question. This design is intentional, 
because as a wise advisor, Vidura is able to assess the baseline proficiency of a user, and 
determine the appropriate amount of guidance for each unique user. For example, Vidura 
will help a user placed in the quadrant defined by low proficiency in both domain and tech-
nology with domain guidance, even if the question is technical in nature. However, as the 
user improves in one or both proficiencies, their placement in the quadrant can shift (for 
more information about the Vidura chatbot, see Chandrashekara et al., 2018). The shifting 
is based on what Gibbs and colleagues (2021) explain as ML algorithms built into organiza-
tional decision-making in HMC research.
Demonstrating the Chatbot’s Role in Gateway Adoption
Fortunati and A. P. Edwards (2020) argue that it is important to consider different meth-
odologies to study HMC. We propose several mixed methods approaches to further study 
Vidura chatbot and identify its role in gateway adoption. First, it is important to conduct a 
market research study on Vidura. To do this, a series of interviews and focus groups can be 
conducted with clinicians and medical researchers combating COVID-19 at the front line, 
to better understand the challenges they face, their needs, routines, and their feedback on 
Vidura. Insights from the initial market research can further identify how the Vidura chat-
bot may meet the needs of the target clinicians and medical researchers.
Second, an experiment can be set up to compare the user outcomes between a control 
group and an experimental group. For example, user outcomes can include task comple-
tion time (start to end time of a search for COVID-19 literature) and success rates (able to 
find the desired COVID-19 literature on gateway or not) between a control group of users 
without the chatbot and the experimental group with the chatbot as the intervention. If 
there are statistically significant differences between the two groups, then the efficiency 
(shorter completion time in the experimental group) and effectiveness (higher success rates 
in the experimental group), then the relative advantages of the chatbot in helping clinicians 
and medical researchers find the COVID-19 literature they need can be demonstrated. 
Also, Lombard and Xu (2021) noted that voice (i.e., human-sounding versus machine- 
sounding) can have an effect on users’ HMC. Moreover, as machines are increasingly 
becoming human-like (Dehnert & Leach, 2021), Davis and Stanovsek (2021) maintain that 
the use of an avatar can create a sense of character identity for the users, which can impact 
HMC. Therefore, different conditions of modality (text versus voice), voice (human- versus 
machine-sounding), and screen-based embodiment (no avatar versus with avatar) can serve 
as variables to compare the two stated outcomes in the experimental group. Additional user 
outcomes can also include satisfaction and likelihood to recommend the gateway with a 
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chatbot to their peers, to further include variables related to diffusion and adoption of the 
KnowCOVID-19 gateway for patient care and medical research in combating the pandemic.
Third, a survey can also follow the experiment. The survey questionnaire can include 
variables such as perception of innovation attributes (Moore & Benbasat, 1991) of the gate-
way and/or the chatbot, self-identified adopter categories (Noppers et al., 2015), opinion 
leadership/super-diffuser tendency (Boster et al., 2011), and demographic variables. Find-
ings can help identify the demographic profiles of clinicians and medical researchers who 
are likely to be in favor of the gateway and/or chatbot. Then the developers can explore using 
the profiles to identify early adopters and opinion leaders to partner with, and pro-actively 
seek out input from the late majority and laggards to identify potential barriers to adoption, 
so the gateway and chatbot can be better designed for diffusion to more effectively and 
efficiently find COVID-19 literature to improve patient care, treatments, and preventions. 
Fourth, the experiment can be video recorded, so the actual points-and-clicks by the 
clinicians and medical researchers can be analyzed by observational techniques to identify 
the usability of the gateway and chatbot. With video recordings, the analysis can focus on 
where these gateway users pause and take a long time to decide the next move. Similar 
analysis can also be performed to identify moments right before the users choose to engage 
with a chatbot, and how they continue with the gateway after receiving guidance and help 
from the chatbot. Such a study can also incorporate the talk out loud strategy, asking the 
users to verbally articulate their thought processes as they navigate the platform. Hence, the 
usability study can better relate the observation of navigation with the analysis of verbalized 
rationales, to help the developers better understand the workflow and routines of clinicians 
and medical researchers during the urgent time of combating COVID-19. 
Fifth, eye-tracking techniques can be utilized to study where clinicians and medical 
researchers focus their eye gaze and visual attention on the KnowCOVID-19 gateway and 
the Vidura chatbot. Similar studies can be conducted to examine the relationships among 
visual attention/distraction to generate heat maps, and correlate the maps with other vari-
ables such as topic involvement and information recall (Gong et al., 2021), in addition to 
what HMC scholars have studied in utilizing eye-tracking software, such as how eye gaze 
signals active participation and intentionality in HMC (McEwen et al., 2020). The heat maps 
can also be used to correlate with findings from data from other studies, such as when users 
initiate a chat session with Vidura, and/or what questions are asked during the chat session.
Sixth, an open-ended interview with clinicians and medical researchers as participants 
immediately following the experiment can also solicit feedback on the design of gateway 
and chatbot for better user experience. Interviewing is particularly well-suited for gath-
ering qualitative input. Furthermore, the analysis can also identify potential background 
factors (such as the thought processes, inherent assumptions, etc. of clinicians and medical 
researchers) that may have affected users’ navigation of the gateway and engagement with 
the chatbot in both positive and negative ways. If a time gap allows for video processing, 
so the interview study is paired up with showing the video recording with talk out loud 
articulation, interviewers can better probe and ask the participant to recall and fully explain 
their experience with the gateway and chatbot, further triangulating different data sources 
and stimuli for a robust analysis. During this interview study, probes should be designed to 
gather a deep understanding of the work context of the clinicians and medical researchers 
during the pandemic, as such insights can help improve the contextual understanding of 
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the COVID-19 pandemic. Interviews can also get at how users may have anthropomor-
phized the chatbot (Liu, 2021), attributing human characteristics to the machine.
Seventh, the verbatim dialogues between the users and the chatbot can be recorded 
and analyzed using conversational analysis techniques, to better understand how clinicians 
and medical researchers engage with the chatbot, and how to design responses for the chat-
bot to optimize the chat process with the least number of back-and-forth (i.e., adjacency 
pairs) between the users and the chatbot before successful task completion. We understand 
that clinicians and medical researchers are very busy, especially during the urgent time of 
combating the pandemic. Such a study can help developers identify the best way to design 
the optimal responses from the chatbot to the clinicians and medical researchers the tech-
nology is designed to serve. Also, this study can add to HMC research and examine self- 
disclosure (Ling & Björling, 2020), and this case, disclosure of questions about accomplish-
ing certain tasks on KnowCOVID-19. Some clinicians and medical researchers may not ask 
certain questions to a human support personnel, but asking these questions to a machine 
advisor may be less embarrassing. 
Finally, as the chatbot can be designed to gather user queries and intents, the data based 
on queries and intents can be further analyzed to identify clinicians and medical researchers 
with similar interests. Then the chatbot can allow these users to opt-in to be recommended 
and receive recommendations to connect with other users with similar interests, thus creat-
ing robust social networks that can lead to a robust user community of clinicians and med-
ical researchers combating the COVID-19 pandemic worldwide. Social network analysis 
can be performed to identify weak ties, strong ties, and where potential ties turn into weak 
ties, and what factors may affect tie strengths and tie conversions across the world. This 
approach is important because HMC scholars have argued that machines can be mediators 
of social relationships (Fortunati & Edwards, 2021), and social influence is a positive pre-
dictor of social machine adoption (Lutz & Tamó-Larrieux, 2020).
Conclusion and Implications
The article set out to answer the research question: “How can an AI-powered chatbot help 
users, especially clinicians and medical researchers, effectively and efficiently identify reliable 
information with high evidence levels to help them make the best decisions at work?” We 
described a gateway called KnowCOVID-19 and the Vidura chatbot being prototyped to 
address this very question. The combination of the gateway and chatbot helps clinicians 
and medical researchers to overcome the big data problem, the quality problem, and the 
diffusion problem. What are the implications of this work?
Theoretically, this study advances diffusion of innovations theory (Rogers, 2003) by 
emphasizing the subsequent stage of sustainable implementation. Much diffusion research 
over-emphasizes the point of adoption, thus rendering sustainable implementation an 
oversight and under-studied area. This is understandable because traditional innovations 
studied in diffusion research are commercial products, and the researchers and companies 
behind are mainly concerned with the point of sales. In the case of gateways, our concern 
is beyond the point of initial adoption, to include meaningful use, widespread diffusion, 
and long-term sustainability in order to enable users to discover breakthrough science and 
research that help them better combat COVID-19.
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Second, much diffusion research has focused on opinion leadership and its impact on 
user adoption. However, less work has been done to investigate if and how helpful machines 
(i.e., chatbots) can support users in properly putting the innovation into practice during 
implementation. This article suggests that the adoption of chatbot with the gateway can help 
users sustain their adoption of the gateway, casting the chatbot and HMC as important for 
promoting and sustaining diffusion. Moreover, as chatbot becomes more commonly used 
in the society, human-chatbot interactions may in turn influence human-human interac-
tions in recent HMC research (Gambino et al., 2020), thus changing how human opinion 
leaders may impact diffusion of innovations.
Third, studying the HMC between users and the chatbot in the use of KnowCOVID-19 
represents an integration of actor-network theory (Latour, 2005) and diffusion theory (Rog-
ers, 2003). Although humans and machines can be argued as ontologically different in HMC 
research (Guzman, 2020; Ling & Björling, 2020), human agents (i.e., clinicians and medical 
researchers) and technical agent (i.e., the Vidura chatbot) can be argued as “potentially 
equivalent actors” (Banks & de Graaf, 2020), hence their collaboration can be treated as 
leading to joint discoveries and identifications of research literature that can guide the best 
evidence-based health care, treatments, and preventions to combat the pandemic. While 
much of early diffusion research was built on quantitative and post-positivistic research, 
the case of KnowCOVID-19 and Vidura chatbot presents an opportunity for theoretical 
extension through a socio-material perspective.
Fourth, the chatbot can follow and track users’ struggles with the gateway all the way 
until the point of discontinuation, if and when it happens. Much diffusion research focuses 
on successful adoption and sometimes implementation, perhaps due to the difficulty of 
finding adopters and/or discontinuers who opted-out to participate in research studies. 
This study suggests an opportunity to leverage chatbots to investigate discontinuation as an 
important decision point in diffusion research.
Practically, many gateway projects are federally funded for the initial development, not 
for long-term sustainability of the gateways. Additionally, there is usually no federal fund-
ing for technical support for users. As a result, implementation of user support is often an 
afterthought, and only recognized as a need when uptake increases notably, and the gateway 
begins to attract many new users beyond the inception projects. Voluntary user support 
by gateway developers when the technologies are in early diffusion cycles may be feasible. 
Once the gateway begins to gain traction in the user community, personalized user sup-
port becomes practically impossible. Scaling to keep up with adoption and guiding users’ 
usage patterns becomes difficult in practice. The Vidura chatbot can solve this problem for 
gateway developers. While receiving support, guidance, and advice from the chatbot may 
appear less than ideal than human support in the early stages, with ML algorithms and 
more interaction data over time, Vidura may outperform human support. This is a possi-
bility similar to the caution that HMC scholars Johanssen and Wang (2021) raised about 
how AI may ultimately surpass human intuition. This possibility is also aligned with the 
concern raised by HMC scholars Piercy and Gist-Mackey (2021), who warned about how 
automation may replace human workers in the future of work.
Furthermore, while the current focus is on literature as text-based data, the gateway 
can further automate data integration with electronic health records (EHR). In order to 
overcome the privacy concerns noted by HMC scholars (Lutz & Tamó-Larrieux, 2020), this 
58 Human-Machine Communication 
integration can be accomplished through privacy measures (Dinakarrao et al., 2019), such 
as using blockchain-based (Matos et al., 2018; Purohit et al., 2021) secure storage layer for 
data from EHR as value-based data analytics. As a result, future users can use the Know-
COVID-19 gateway to perform joint analysis with EHR data in concert with publication 
analytics research. 
Moreover, the work on chatbot can also be extended to social robots (Banks et al., 
2021), which has a three-dimensional embodiment and the ability to take in multiple sen-
sory inputs, such as nonverbal cues, body temperature, and so forth from users. Social 
robots are also capable of conveying nonverbal cues to users, creating complex interactions 
to promote innovation adoption. Social robots can also be used in dangerous and/or haz-
ardous environments, thus providing another means for protecting human agents from 
physical harms.
Finally, this article highlights the difference between innovations and diffusion, by 
putting the emphasis on the latter. While the KnowCOVID-19 gateway may be a good 
innovation, without the Vidura chatbot, adoption and diffusion over the long-term can 
be compromised. Similar to how vaccine for COVID-19 is an important innovation, vac-
cination is a separate science and is equally important for research attention. In other 
words, innovations cannot fully realize their societal impacts without the help of diffu-
sion research. We argue that HMC, such as in the case of chatbots, can play an important 
role in the adoption of new technologies and other important innovation in the context of 
COVID-19. HMC insights can also be extended to the post-pandemic world and increase 
our preparedness for the next global crisis. 
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